Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Drugs@FDA
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Women's Issues in Multiple Sclerosis.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
CombiRx for MS not better than monotherapy
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Myelinating satellite oligodendrocytes are integrated in a glial syncytium constraining neuronal high-frequency activity.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Susceptibility tensor imaging (STI) of the brain.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Neuro-Immune Interactions at Barrier Surfaces.
Timing of birth and risk of multiple sclerosis: population based study.
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
Assessment of structural and functıonal vısual outcomes ın relapsıng remıttıng multıple sclerosıs wıth vısual evoked potentıals and optıcal coherence tomography.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
Genzyme receives positive CHMP opinion for LEMTRADA™ (alemtuzumab) in Europe
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »